LCA-Vision Inc.  

(Public, NASDAQ:LCAV)   Watch this stock  
Find more results for LCA-Vision Inc
5.35
+0.01 (0.09%)
Apr 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.34 - 5.35
52 week 2.97 - 5.69
Open 5.35
Vol / Avg. 75,935.00/144,139.00
Mkt cap 103.01M
P/E     -
Div/yield     -
EPS -0.07
Shares 19.25M
Beta 4.38
Inst. own 63%
May 7, 2014
LCA-Vision Extraordinary Shareholder Meeting - 9:00AM EDT - Add to calendar
Apr 29, 2014
Q1 2014 LCA-Vision Earnings Release - 9:30AM EDT - Add to calendar
Feb 18, 2014
Q4 2013 LCA-Vision Earnings Release
Feb 14, 2014
PhotoMedex, Inc. Signs Definitive Agreement to Acquire LCA-Vision Conference Call - Webcast
Jan 21, 2014
LCA-Vision at Noble Financial Equity Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -7.16% -1.48%
Operating margin -8.27% -2.59%
EBITD margin - -0.34%
Return on average assets -13.62% -2.98%
Return on average equity -29.89% -7.03%
Employees 363 -
CDP Score - -

Address

7840 MONTGOMERY RD
CINCINNATI, OH 45236
United States - Map
+1-513-7929292 (Phone)
+1-513-7925620 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

Officers and directors

Michael J. Celebrezze Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Amy F. Kappen Chief Financial Officer
Age: 42
Bio & Compensation  - Reuters
Bharat Kakar Senior Vice President - Operations and Marketing
Age: 44
Bio & Compensation  - Reuters
Rhonda S. Sebastian Senior Vice President - Human Resources
Age: 59
Bio & Compensation  - Reuters
E. Anthony Woods Non-Executive Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William F. Bahl Independent Director
Age: 62
Bio & Compensation  - Reuters
John C. Hassan Independent Director
Age: 70
Bio & Compensation  - Reuters
Edgar F. Heizer III Independent Director
Age: 53
Bio & Compensation  - Reuters
James C. Wachtman Independent Director
Age: 52
Bio & Compensation  - Reuters